Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
News Menu

News

News

Tue, Mar 19th, 2019
NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study

LUND, Sweden , March 19, 2019 /PRNewswire/ --  NeuroVive Pharmaceutical AB  (Nasdaq Stockholm: NVP, OTCQX: NEVPF)  today announced that the first healthy volunteer in the company's...

Shineco, Inc. Establishes Subsidiary to Capture Industrial Cannabis Market Growth

BEIJING , March. 18, 2019 /PRNewswire/ -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural produce, specialized...

TYHT : 0.66 (-2.21%)
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-CD47 Monoclonal Antibody in the U.S.

SUZHOU, China , March  18 , 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines,...

Apollo Medical Holdings Reports 46% Revenue Increase For 2018

ALHAMBRA, Calif. and GLENDALE, Calif. , March 18, 2019 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed" or the "Company") (NASDAQ: AMEH), an integrated population health management...

AMEH : 19.09 (-6.60%)
Corcept (CORT) Class Action Lawsuit: Bernstein Liebhard LLP Announces A Securities Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

NEW YORK , March 18, 2019 /PRNewswire/ -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of...

CORT : 12.31 (+1.15%)
CannTrust Announces Filing of Final Base Shelf Prospectus

VAUGHAN, ON , March 18, 2019 /PRNewswire/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX:TRST, NYSE:CTST) announces that it has filed a (final) short form base shelf prospectus (the...

CTST : 9.50 (+6.98%)
TRST.TO : 12.68 (+6.64%)
Perrigo Announces Tentative FDA Approval For The Generic Version Of Finacea® Foam, 15%

DUBLIN , March 18, 2019 /PRNewswire/ -- Perrigo Company plc (NYSE; TASE: PRGO) a leading global provider of "Quality, Affordable, Self-Care Products™" today announced it has received tentative approval...

PRGO : 48.67 (+1.08%)
Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress

TEL AVIV, Israel , March 18, 2019 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of a novel stem cell production technology, today announced operating and financial results...

APOP : 1.03 (+0.79%)
Moleculin Announces Memorial Sloan Kettering Chief of Leukemia Joins Science Advisory Board

HOUSTON , March 18, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates...

MBRX : 1.25 (-1.57%)
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

ROCKFORD, Ill. , March 18, 2019 /PRNewswire/ -- Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL tothe consumer/user level. The...

MYL : 28.18 (+0.32%)
Wolters Kluwer Launches the Health Regulatory Change Analyzer for Healthcare Regulatory and Compliance Attorneys

NEW YORK , March 18, 2019 /PRNewswire/ --  Wolters Kluwer Legal & Regulatory U.S.  today launched the Health Regulatory Change Analyzer, a first-of-its-kind legal research solution designed...

WTKWY : 67.4300 (+0.22%)
BIOREM Reports 8% Increase in Revenue, Earnings of $4.7 million and EPS of $0.12

GUELPH, ON , March 18, 2019 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("BIOREM" or "the Company") today announced its results for the three and twelve-month periods ended December 31, 2018 . BIOREM's...

BRM.VN : 0.430 (+13.16%)
BIRMF : 0.2894 (unch)
WuXi Biologics Continues to Deliver Record Results

HONG KONG , March 18, 2019 /PRNewswire/ -- WuXi Biologics (Cayman) Inc. ( " WuXi Biologics "  or " the Group ",  stock code: 2269.HK) , a leading global open-access...

WXXWY : 20.7290 (+1.36%)
Agrios Global Holdings Ltd. Appoints Michael Hammer, as Strategic Advisor

VANCOUVER , March 18, 2019 /PRNewswire/ - Agrios Global Holdings Ltd. (CSE: AGRO) (OTCQB: AGGHF) (FSE: ØSA - WKN-A2N62K) ("Agrios" or the "Company") today announced that it has appointed Mr. ...

AGGHF : 0.4760 (-5.91%)
AGRO : 7.01 (+0.72%)
Bruker Highlights New Systems and Applied Market Solutions at Pittcon

PHILADELPHIA , March 18, 2019 /PRNewswire/ -- At Pittcon 2019, Bruker (Nasdaq: BRKR) this week highlights new and innovative analytical systems and high-value applied market solutions for food analysis,...

BRKR : 39.26 (+1.00%)
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Hosts Medical Cannabis Event in Bahia

SAN DIEGO , March 18, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its subsidiary...

MJNA : 0.0645 (-1.83%)
Pulpo Launches New Brand Focused On Three-Core Digital Services: Media, Custom Solutions And Engaging Content

SANTA MONICA, Calif. , March 18, 2019 /PRNewswire/ --  Pulpo , an  Entravision Communications Corporation  (NYSE: EVC) company, today announced new branding that more intuitively conveys...

BDX : 244.67 (-3.64%)
EVC : 3.71 (+0.54%)
Vascepa® (icosapent ethyl) Showed 30% Reduction in Total Cardiovascular Events Including Recurrent Events in REDUCE-IT™

BEDMINSTER, N.J. and DUBLIN , March 18, 2019 /PRNewswire/ -- Amarin Corporation plc (NASDAQ: AMRN), presented new data from its landmark cardiovascular outcomes study of its prescription therapy,...

AMRN : 19.30 (-5.07%)
DarioHealth to Host Fourth Quarter and Year End 2018 Conference Call March 25, 2019

NEW YORK and CAESAREA, Israel , March 18, 2019 /PRNewswire/ -- Global digital therapeutics innovation leader DarioHealth Corp.  (NASDAQ: DRIO) today announced it will release its...

DRIO : 0.68 (-6.07%)
Thermo Fisher Scientific to Invest $150 Million to Expand Pharma Services Capabilities

WALTHAM, Mass. , March 18, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it is investing $150 million in its Pharma...

TMO : 263.53 (+0.17%)

Chart of the Day

Oracle Corp (ORCL)

Read today's promising find and trading idea for the stock market.The Chart of the Day belongs to Oracle (ORCL). I found the stock by using Barchart.com to find the "Barchart New Highs" page and then I clicked on pull-down to select stocks w...
Read More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar